. .
.
. Mayo Clinic Health Solutions
.
. .
.
Search:
Browse Categories:
  arrow Research Tools
arrow
  arrow Diagnostics
arrow
  arrow Therapeutics
arrow
  arrow Medical Devices
arrow
  arrow Electronic Devices
arrow
  arrow Software
arrow
  arrow All Listings
arrow
arrow
  Home
arrow
  About Us
arrow
  Contact Us
arrow
arrow
  Go to mayoclinic.org
arrow
  Go to Research at Mayo Clinic
arrow
Mayo Clinic Technology
.

Prostate Marker Validation Database

Reference #:

2005-231

Inventors/Contributors

George G. Klee, M.D., Ph.D., George Vasmatzis, Ph.D., Farhad Kosari, Ph.D., John C. Cheville, M.D., Cemile D. Savci Heijink, M.D., Eric W. Klee, Ph.D.

Description

Under the Minnesota Partnership, researchers at the University of Minnesota and at Mayo have developed a database for use in the evaluation of potential prostate cancer biomarkers. Researchers have profiled gene expression of benign and malignant cells that were laser capture microdissected (LCM) from prostate tissues and metastatic adenocarcinomas. In addition, researchers have conducted localization analyses using bioinformatics techniques. This database can be used to evaluate potential new markers. Reports can be generated and provided to companies/investigators seeking additional data to help evaluate candidate prostate biomarkers.

Patent Status

None

Contact

Nathan L. Stacy, Licensing Manager
stacy.nathan@mayo.edu

Mayo Foundation for Medical Education and Research
Office of Technology Commercialization
Centerplace 4
200 First Street SW
Rochester, MN 55905

Phone: (507) 538-1652
Fax: (507) 284-5410